DaVita Inc reports results for the quarter ended September 30 - Earnings Summary
DaVita Inc reports results for the quarter ended September 30 - Earnings Summary
DaVita Inc DVA.N reported quarterly adjusted earnings of $3.40 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.04. The mean expectation of seven analysts for the quarter was for earnings of $3.61 per share. Wall Street expected results to range from $3.41 to $4.03 per share.
Revenue rose 4.6% to $3.58 billion from a year ago; analysts expected $3.51 billion.
DaVita Inc's reported EPS for the quarter was $3.40.
The company reported quarterly net income of $222.93 million.
DaVita Inc shares had risen by 5.2% this quarter and gained 61.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 8% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for DaVita Inc is $220.00, about 12.1% above its last closing price of $193.31
This summary was machine generated from LSEG data October 29 at 10:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 3.61 | 3.40 | Missed |
Jun. 30 2026 | 3.88 | 4.02 | Beat |
Mar. 31 2026 | 2.32 | 2.87 | Beat |
Dec. 31 2025 | 3.16 | 3.40 | Beat |
Recent news on Davita
See all newsDaVita Inc reports results for the quarter ended September 30 - Earnings Summary
DaVita lifts lower end of 2026 profit forecast, shares fall
DaVita buys back $69 million shares from Berkshire, which retains 45% stake
Corrected: DaVita Q3 revenue beat analyst estimates on increased average reimbursement rates
Brief: DaVita Q3 Revenue USD 3,578 Million Vs. IBES Estimate USD 3,508 Million